Pamela Martyn-Nemeth1, Shane A Phillips2,3, Dan Mihailescu3, Sarah S Farabi4, Chang Park1, Rebecca Lipton5, Esema Idemudia1, Laurie Quinn1. 1. Department of Biobehavioral Health Science, College of Nursing, University of Illinois at Chicago, Chicago, Illinois. 2. Department of Physical Therapy, College of Applied Health Sciences, University of Illinois at Chicago, Chicago, Illinois. 3. College of Medicine, Endocrinology, Diabetes & Metabolism, University of Illinois at Chicago, Chicago, Illinois. 4. Division of Endocrinology, Metabolism & Diabetes, School of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, Colorado. 5. Departments of Pediatrics and Public Health Sciences, University of Chicago, Chicago, Illinois.
Abstract
AIMS: To examine sleep quality and its associations with glycaemic control, glycaemic variability (GV), and fear of hypoglycaemia (FOH) in adults with type 1 diabetes. BACKGROUND: Poor sleep quality has negative health consequences and is a frequent complaint among adults with type 1 diabetes. Sleep quality in adults with type 1 diabetes is likely affected by glucose levels as well as stressors associated with managing a chronic condition. DESIGN: A retrospective secondary analysis of pooled data from two previous cross-sectional studies was conducted. METHODS: We examined subjective sleep quality, FOH; objective measures of glycaemic control (HbA1c); and GV (3-day continuous glucose monitoring) in 48 men and women aged 18-45 years with type 1 diabetes. The data were collected over 3 years in 2013-2016. RESULTS/ FINDINGS: Poor sleep quality was reported by 46% of patients. Those with poor sleep quality had significantly greater nocturnal GV and FOH. Nocturnal GV and FOH were significantly associated with poor sleep quality. The interaction effect of GV and FOH was significant. CONCLUSION: These findings suggest that glycaemic control and FOH are targets for intervention to improve sleep quality in those with type 1 diabetes.
AIMS: To examine sleep quality and its associations with glycaemic control, glycaemic variability (GV), and fear of hypoglycaemia (FOH) in adults with type 1 diabetes. BACKGROUND: Poor sleep quality has negative health consequences and is a frequent complaint among adults with type 1 diabetes. Sleep quality in adults with type 1 diabetes is likely affected by glucose levels as well as stressors associated with managing a chronic condition. DESIGN: A retrospective secondary analysis of pooled data from two previous cross-sectional studies was conducted. METHODS: We examined subjective sleep quality, FOH; objective measures of glycaemic control (HbA1c); and GV (3-day continuous glucose monitoring) in 48 men and women aged 18-45 years with type 1 diabetes. The data were collected over 3 years in 2013-2016. RESULTS/ FINDINGS: Poor sleep quality was reported by 46% of patients. Those with poor sleep quality had significantly greater nocturnal GV and FOH. Nocturnal GV and FOH were significantly associated with poor sleep quality. The interaction effect of GV and FOH was significant. CONCLUSION: These findings suggest that glycaemic control and FOH are targets for intervention to improve sleep quality in those with type 1 diabetes.
Authors: Stephanie Feudjio Feupe; Patrick F Frias; Sara C Mednick; Elizabeth A McDevitt; Nathaniel D Heintzman Journal: J Diabetes Sci Technol Date: 2013-09-01
Authors: Michelle M Perfect; Priti G Patel; Roxanne E Scott; Mark D Wheeler; Chetanbabu Patel; Kurt Griffin; Seth T Sorensen; James L Goodwin; Stuart F Quan Journal: Sleep Date: 2012-01-01 Impact factor: 5.849
Authors: Rocío Romero-Castillo; Manuel Pabón-Carrasco; Nerea Jiménez-Picón; José Antonio Ponce-Blandón Journal: Int J Environ Res Public Health Date: 2022-04-21 Impact factor: 4.614
Authors: Alia García; Vanessa Moscardó; Agustín Ramos-Prol; Julián Díaz; Miguel Boronat; Jorge Bondia; Paolo Rossetti Journal: BMJ Open Diabetes Res Care Date: 2021-10
Authors: Alba Maestro-Gonzalez; Marta Sánchez-Zaballos; María Pilar Mosteiro-Díaz; David Zuazua-Rico Journal: Sleep Med Date: 2021-02-02 Impact factor: 4.842
Authors: Uffe Søholm; Melanie Broadley; Natalie Zaremba; Patrick Divilly; Giesje Nefs; Zeinab Mahmoudi; Bastiaan de Galan; Ulrik Pedersen-Bjergaard; Alan Brennan; Daniel John Pollard; Rory J McCrimmon; Stephanie A Amiel; Christel Hendrieckx; Jane Speight; Pratik Choudhary; Frans Pouwer Journal: BMJ Open Date: 2022-02-01 Impact factor: 2.692